Evidence map›Paper›PMID 41169479›Full record

ReviewFrontiers in endocrinology2025

Inosine: biofunctions and the roles in human diseases.

Fangwei Li, Jiawen Zhang, Jiayi Kang, Xuemei Tong, Ping Zhang, Yemin Zhu

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fangwei Li *Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiawen Zhang *Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiayi Kang *Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xuemei TongDepartment of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ping ZhangDepartment of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yemin ZhuDepartment of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inosine, a basic component of purine nucleotide, is mainly seen only as a building block in nucleotide synthesis. It is also a versatile bioactive molecule with diverse biofunctions. These biofunctions are strongly related to human diseases or pathological conditions, such as cancer, obesity, inflammation, neurodegenerative diseases, and autoimmune diseases. In this article, we will discuss the roles and functions of inosine in a wide array of human diseases, targeting metabolism modulation, purinergic signaling, and RNA editing. We will also mention its great importance as a biomarker of human diseases. We believe that a more thorough understanding of inosine and its intricate roles in various human diseases could inspire future therapeutic methods or preventive modalities for these diseases.

Indexed as

InosineNeoplasmsNeurodegenerative DiseasesAnimalsAutoimmune DiseasesHumansInflammationObesityRNA EditingSignal TransductionInosinehuman diseasesinosinemetabolismpurinergic signalingRNA editing

Identifiers

PMID41169479
PMCPMC12568433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.